tenk.fyi

Replimune Group, Inc.

REPLNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$247.3M

14.6% YoY

EPS

$-3.07

5.2% YoY

Cash

$111.1M

49.2% YoY

FY 2025 · As of 2025-03-31